Literature DB >> 20427498

Missense mutations in the melanocortin 2 receptor accessory protein that lead to late onset familial glucocorticoid deficiency type 2.

C R Hughes1, T T Chung, A M Habeb, F Kelestimur, A J L Clark, L A Metherell.   

Abstract

BACKGROUND: Familial glucocorticoid deficiency (FGD) is an autosomal recessive disorder characterized by isolated glucocorticoid deficiency. Mutations in the ACTH receptor [melanocortin 2 receptor (MC2R)] or the MC2R accessory protein (MRAP) cause FGD types 1 and 2, respectively. Typically, type 2 patients present early (median age, 0.1 yr), and no patient reported to date has presented after 1.6 yr. AIM: The aim of this study was to investigate the cause of disease in two families with late-onset FGD. PATIENTS: The proband in family 1 was diagnosed at age 4 yr. Family review revealed two older siblings with undiagnosed FGD. One sibling was well, whereas the second had cerebral palsy secondary to hypoglycemic seizures. The proband in family 2 was diagnosed at age 18 yr with symptoms of fatigue, weight loss, and depression.
METHODS: The coding exons of MC2R and MRAP were sequenced. ACTH dose-response curves were generated for MC2R when transfected with wild-type or mutant MRAP constructs using HEK293 cells. MC2R trafficking with both mutant MRAPs was investigated using immunocytochemistry.
RESULTS: MRAP gene analysis identified two novel homozygous missense mutations, c.175T>G (pY59D) in family 1 and c.76T>C (p.V26A) in family 2. In vitro analysis showed that the Y59D mutant had significant impairment of cAMP generation, and both mutants caused a shift in the dose-response curve to the right when compared to wild type. Immunocytochemistry showed normal trafficking of MC2R when transfected with both mutant MRAPs, indicating a probable signaling defect.
CONCLUSION: These results indicate that missense MRAP mutations present with a variable phenotype of ACTH resistance and can present late in life.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427498     DOI: 10.1210/jc.2009-2731

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  G protein-coupled receptors: mutations and endocrine diseases.

Authors:  Gilbert Vassart; Sabine Costagliola
Journal:  Nat Rev Endocrinol       Date:  2011-02-08       Impact factor: 43.330

2.  Familial glucocorticoid deficiency: a diagnostic challenge during acute illness.

Authors:  Abdelhadi M Habeb; Claire R Hughes; Rida Al-Arabi; Ali Al-Muhamadi; Adrian J L Clark; L A Metherell
Journal:  Eur J Pediatr       Date:  2013-05-26       Impact factor: 3.183

3.  Neonatal presentation of familial glucocorticoid deficiency resulting from a novel splice mutation in the melanocortin 2 receptor accessory protein.

Authors:  V Jain; L A Metherell; A David; R Sharma; P K Sharma; A J L Clark; L F Chan
Journal:  Eur J Endocrinol       Date:  2011-09-27       Impact factor: 6.664

Review 4.  Melanocortin receptor accessory proteins in adrenal disease and obesity.

Authors:  David S Jackson; Shwetha Ramachandrappa; Adrian J Clark; Li F Chan
Journal:  Front Neurosci       Date:  2015-06-10       Impact factor: 4.677

5.  The melanocortin receptors and their accessory proteins.

Authors:  Shwetha Ramachandrappa; Rebecca J Gorrigan; Adrian J L Clark; Li F Chan
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-08       Impact factor: 5.555

6.  Whole-Exome Sequencing in the Differential Diagnosis of Primary Adrenal Insufficiency in Children.

Authors:  Li F Chan; Daniel C Campbell; Tatiana V Novoselova; Adrian J L Clark; Louise A Metherell
Journal:  Front Endocrinol (Lausanne)       Date:  2015-08-05       Impact factor: 5.555

7.  Rare Causes of Primary Adrenal Insufficiency: Genetic and Clinical Characterization of a Large Nationwide Cohort.

Authors:  Tulay Guran; Federica Buonocore; Nurcin Saka; Mehmet Nuri Ozbek; Zehra Aycan; Abdullah Bereket; Firdevs Bas; Sukran Darcan; Aysun Bideci; Ayla Guven; Korcan Demir; Aysehan Akinci; Muammer Buyukinan; Banu Kucukemre Aydin; Serap Turan; Sebahat Yilmaz Agladioglu; Zeynep Atay; Zehra Yavas Abali; Omer Tarim; Gonul Catli; Bilgin Yuksel; Teoman Akcay; Metin Yildiz; Samim Ozen; Esra Doger; Huseyin Demirbilek; Ahmet Ucar; Emregul Isik; Bayram Ozhan; Semih Bolu; Ilker Tolga Ozgen; Jenifer P Suntharalingham; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2015-11-02       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.